Events

CureVac N.V. (Nasdaq: CVAC), has reported financial results and provided business updates for the fourth quarter and full-year 2022 on Tuesday, April 25, 2023. The company hosted a conference call and webcast on the same day.

Please find the corresponding press release, the presentation slides and the transcript below. A link to the replay of the webcast is available via the link below.

Link to webcast

Extraordinary general meeting of shareholders

March 28, 2023

Amsterdam

Downloads

Pressemitteilung
Präsentation (Englischsprachig)
Transkript (Englischsprachig)

Link to EGM

SVB Securities Global Biopharma Conference

February 16, 2023

Virtual

Downloads

Pressemitteilung
Präsentation (Englischsprachig)
Transkript (Englischsprachig)

Press Release: CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs

January 30, 2023

Link to webcast

J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco

January 9 to 11, 2023

San Francisco

Downloads

Pressemitteilung
Präsentation (Englischsprachig)
Transkript (Englischsprachig)

Link to meeting request

Conference Call & Webcast – CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs

January 6, 2023

CureVac N.V. (Nasdaq: CVAC) today announced positive preliminary data from ongoing Phase 1 clinical programs in COVID-19 and seasonal flu, assessing both modified and unmodified mRNA technology.
The company hosted a conference call and webcast. Please find below the download link for the press release and the presentation slides as well as the link to the on demand version of the webcast.

Link to webcast

The JMP Securities Hematology and Oncology Summit

December 6, 2022

Virtual

Downloads

Pressemitteilung
Präsentation (Englischsprachig)
Transkript (Englischsprachig)

Link to webcast

5th Annual Evercore ISI HealthCONx Conference

November 29, 2022

Virtual

Downloads

Pressemitteilung
Präsentation (Englischsprachig)
Transkript (Englischsprachig)

Link to webcast

Jefferies London Healthcare Conference

November 17, 2022

London

Downloads

Pressemitteilung
Präsentation (Englischsprachig)
Transkript (Englischsprachig)

Link to webcast

Third Quarter and First Nine Months 2022 Financial Results and Business Updates – Conference Call & Webcast

November 16, 2022

CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2022 on Wednesday, November 16, 2022. The company hosted a conference call and webcast on the same day.

Please find the corresponding press release and presentation slides below. A link to the replay of the webcast will be made available shortly.